Pharmacokinetics and Safety of Ferric Pyrophosphate Citrate in Chinese Subjects with and without Hemodialysis-Dependent Stage 5 Chronic Kidney Disease Publication Pharmacokinetics and Safety of Ferric Pyrophosphate Citrate in Chinese Subjects with and without Hemodialysis-Dependent Stage 5 Chronic Kidney Disease Discover how evaluated ferric pyrophosphate citrate pharmacokinetics and safety in healthy and hemodialysis‑dependent CKD patients…Certara2022 年 4 月 5 日
Population Pharmacokinetic (Pop-PK) Analysis of Torsemide in Healthy Korean Males Considering CYP2C9 and OATP1B1 Genetic Polymorphisms Publication Population Pharmacokinetic (Pop-PK) Analysis of Torsemide in Healthy Korean Males Considering CYP2C9 and OATP1B1 Genetic Polymorphisms Explore how CYP2C9 and OATP1B1 genetic effects on torsemide PK in healthy Korean males, supporting…Certara2022 年 4 月 1 日
Co-Administration with Voriconazole Doubles the Exposure of Ruxolitinib in Patients with Hematological Malignancies Publication Co-Administration with Voriconazole Doubles the Exposure of Ruxolitinib in Patients with Hematological Malignancies Find out how voriconazole more than doubles ruxolitinib exposure, supporting dose adjustment guidance for hematologic…Certara2022 年 3 月 25 日
Comparative pharmacokinetics and tissue distribution of primaquine enantiomers in mice Publication Comparative pharmacokinetics and tissue distribution of primaquine enantiomers in mice See how major PK and metabolic differences between primaquine enantiomers, informing safer and more effective…Certara2022 年 2 月 5 日
Bioequivalence and Safety Assessment of Two Formulations of Metformin Hydrochloride Sustained-Release Tablets (Yuantang® SR and Glucophage® XR) Under Fed Conditions in Healthy Chinese Adult Subjects: An Open-Label, Two-Way Crossover, Sequence Randomized Phase I Clinical Trial Publication Bioequivalence and Safety Assessment of Two Formulations of Metformin Hydrochloride Sustained-Release Tablets (Yuantang® SR and Glucophage® XR) Under Fed Conditions in Healthy Chinese Adult Subjects: An Open-Label, Two-Way Crossover, Sequence Randomized Phase I Clinical Trial Learn how the confirmed bioequivalence of metformin SR formulations under fed conditions, with matched PK…Certara2022 年 1 月 21 日
The effect of nutritional status on the pharmacokinetic profile of acetaminophen+A124:N124 Publication The effect of nutritional status on the pharmacokinetic profile of acetaminophen+A124:N124 Explore how nutritional status strongly alters acetaminophen PK at toxic doses, with low‑protein diets producing…Certara2022 年 1 月 20 日
Application of Population Pharmacokinetic Analysis to Characterize CYP2C19 Mediated Metabolic Mechanism of Voriconazole and Support Dose Optimization Publication Application of Population Pharmacokinetic Analysis to Characterize CYP2C19 Mediated Metabolic Mechanism of Voriconazole and Support Dose Optimization Discover how major CYP2C19 genotype effects on voriconazole PK, supporting genotype‑guided dose adjustments to avoid…Certara2022 年 1 月 3 日
The impact of rifampicin on the pharmacokinetics of fuzuloparib in healthy Chinese male volunteers Publication The impact of rifampicin on the pharmacokinetics of fuzuloparib in healthy Chinese male volunteers See how rifampicin reduces fuzuloparib exposure by up to 90%, confirming a major CYP3A4 induction…Certara2021 年 12 月 26 日
Pharmacokinetics of oral vinorelbine in French children with recurrent or progressive primary low-grade glioma Publication Pharmacokinetics of oral vinorelbine in French children with recurrent or progressive primary low-grade glioma Find out how lower vinorelbine exposure in children and strong BSA effects, supporting dose refinement…Certara2021 年 12 月 13 日
Population Pharmacokinetics of Polymyxin B in Obese Patients for Resistant Gram-Negative Infections Publication Population Pharmacokinetics of Polymyxin B in Obese Patients for Resistant Gram-Negative Infections Learn how adjusted‑body‑weight dosing optimises polymyxin B exposure in obese patients, avoiding toxicity while achieving…Certara2021 年 11 月 22 日